NL-OMON39106
Completed
N/A
utritional deficiencies in children with Attention Deficit/Hyperactivity Disorder: A focus on amino acids - Nutrients and ADHD.
Ansynth Service B.V.0 sites187 target enrollmentTBD
Overview
- Phase
- N/A
- Intervention
- Not specified
- Conditions
- Attention-deficit/hyperactivity disorder
- Sponsor
- Ansynth Service B.V.
- Enrollment
- 187
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
Trial is onging in other countries
Investigators
Eligibility Criteria
Inclusion Criteria
- •For both groups (the clinical group that consists of children with ADHD and the reference group) the inclusion criteria are that children are (a) between 6 and 13 years old and (b) in grade 1 to 6 from elementary school. Children in the clinical group have received a clinical diagnosis of ADHD, confirmed by standardized assessments.
Exclusion Criteria
- •There is one exclusion criterion for the clinical group and that is that children will not be able to participate when they use methylphenidate (MPH) during the testing. The behaviour and functioning of children should not be influenced by medication when they will be assessed. Children who are receiving a psychopharmacological treatment for ADHD could discontinue their treatment for a short period in order to be able to participate. After the discontinuation of stimulant use, a complete washout will be achieved within 48 hours (Pelham et al., 1999\). Therefore, the medication break could be limited to five days (two days before the testing period and three days of testing). Stimulant medication is often discontinued (initiated by parents) during weekends or school\-holidays in order to limit the consequences of the negative side effects associated with the use of MPH. The decision for a medication break of five days will be taken in consultation with the responsible psychiatrist of the child.
- •There will be no exclusion criteria for comorbid disorders that frequently co\-occur with ADHD, such as oppositional defiant disorder (ODD), conduct disorder (CD), autism spectrum disorder (ASD) or learning disorders. Using these exclusion criteria would decrease the probability of having a representative sample.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
N/A
Safeguarding the brain of our smallest children ;* an investigator-initiated randomised, blinded, multinational, phase II feasibility clinical trial on near-infrared spectroscopy monitoring combined with defined treatment guidelines versus standard monitoring and treatment as usual in premature infantscerebral hypoxiacerebral oxygenation1002930510028920NL-OMON37782Region Hovestaden, Department of Neonatology 5024, Rigshospitalet11
Completed
N/A
Hemostasis in pediatric patients undergoing orthotopic liver transplantation: a prospective cohort study.NL-OMON45316niversitair Medisch Centrum Groningen50
Completed
N/A
Treatment of electroencephalographic status epilepticus after cardiopulmonary resuscitatioNL-OMON50403Ziekenhuis Rijnsate171
Completed
N/A
A Prospective, Multi-Center Study of the IlluminOss® Photodynamic Bone Stabilization System for the Treatment of Impending and Actual Pathological Fractures in the Humerus from Metastatic Bone Diseasebone healingupper arm fracture1001732210005944NL-OMON40648IlluminOss Medical In.4
Completed
N/A
A prospective, multi-centre study investigating the incidence and prognosis of relapses, pseudo-relapses and other causes of (sub)acute neurological symptoms in patients with relapsing-remitting multiple sclerosis.NL-OMON55562Sint Elisabeth Ziekenhuis125